Calcium Hypochlorite Biocides 2026: what changes in EU authorization and what companies must review

Key data

If your company manufactures, distributes or professionally uses calcium hypochlorite-based biocides, you have an active review obligation from 4 June 2026. The Implementing Regulation (EU) 2026/1331 modifies Regulation (EU) 2025/831 and introduces administrative and minor changes to the Union authorization for the AWPF Calcium Hypochlorite BPF biocides family. Although the changes do not affect the product formula or conditions of use, regulatory compliance requires verification of the associated documentation.

What does this regulation establish?

Regulation (EU) 2026/1331 modifies Implementing Regulation (EU) 2025/831, which is the base standard that regulates the Union authorization for the AWPF Calcium Hypochlorite BPF biocides family. This Union authorization allows the product to be marketed in all Member States under harmonized conditions, without the need for individual national authorizations.

The changes introduced are of an administrative and minor nature, which according to European biocides regulation may include:

• Updates to the authorization holder's data (name, address, contact details).
• Adjustments to the technical documentation of the file.
• Formal corrections with no impact on the chemical composition of the product.
• Modifications that do not alter the authorized conditions of use.

The modified base standard, Regulation (EU) 2025/831, established the original authorization conditions. The new Regulation (EU) 2026/1331 does not repeal it: it updates it punctually in the administrative and minor aspects indicated.

Economic and operational impact

Although the changes are administrative, the operational impact for companies is not negligible. The Union authorization is the enabling document for marketing the product throughout the EU. Any modification, however minor, can trigger cascading documentary update obligations:

• Product labels: If administrative changes affect the name or data of the authorization holder, labels must reflect the updated information. Marketing with outdated labels may constitute regulatory non-compliance.
• Safety data sheets (SDS): The section relating to authorization and the holder must be aligned with the current version of the Regulation.
• National registers: Some Member States maintain their own registers of marketed biocide products. If the holder's data or technical documentation has changed, it may be necessary to notify the competent national authorities.
• Contracts and commercial documentation: Distributors and professional users who reference the authorization in their contracts or internal procedures must verify that regulatory references are up to date.

The direct cost of adaptation depends on the volume of labeled products in stock, the number of markets in which the company operates and the complexity of its document management systems. There is no specific penalty amount published in this regulation, but non-compliance with the conditions of the Union authorization may result in restrictions on marketing.

Who does it affect?

• Manufacturers of calcium hypochlorite biocides operating under the AWPF Calcium Hypochlorite BPF Union authorization.
• Distributors marketing these products in one or more EU Member States.
• Professional users in the water treatment sector (drinking water, wastewater, swimming pools) who use these biocides in their processes.
• Industrial disinfection companies that use calcium hypochlorite as an active agent.
• Regulatory compliance officers and product technicians in chemical and industrial hygiene companies.
• Advisors and consultants who manage the regulatory file for these products for their clients.

Practical example

A Spanish distribution company that markets products from the AWPF Calcium Hypochlorite BPF family in Spain, France and Portugal has batches in stock labeled with the authorization holder's data according to Regulation (EU) 2025/831. Following the publication of Regulation (EU) 2026/1331 on 16 June 2026, it must:

1. Consult the text of the new regulation to identify exactly what holder data has changed.
2. Determine whether the current labels of the batches in stock reflect information that is no longer valid.
3. Coordinate with the manufacturer holding the authorization to obtain updated documentation (safety data sheets, technical specifications).
4. Notify, if applicable, the competent authorities in Spain, France and Portugal if national registers require updating.

If the changes are exclusively internal to the holder's file and do not affect the data appearing on the label, the operational impact for the distributor may be minimal. The key is to verify the specific scope of the changes in the official text.

What should companies do now?

1. Read the full text of Regulation (EU) 2026/1331 to identify exactly what data or documents have been modified compared to Regulation (EU) 2025/831.
2. Review current labels of all products marketed under the AWPF Calcium Hypochlorite BPF authorization and check whether any data affected by the change appears on them.
3. Update safety data sheets (SDS) if the authorization holder's information or technical data has changed.
4. Verify national registers in each Member State where the product is marketed and notify changes if national regulations require it.
5. Communicate internally to logistics, sales and customer service teams any changes in the documentation accompanying the product.
6. Archive the updated version of the Regulation in the product's regulatory file for future inspections or audits.

Official source

Consult complete regulation in official source

Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202601331